日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SC134-deruxtecan, a fucosyl-GM1 targeting ADC for small cell lung cancer therapy.

SC134-deruxtecan,一种靶向岩藻糖基-GM1的抗体药物偶联物,用于治疗小细胞肺癌

Heath Bryony, Kaira Bubacarr G, Thakker Dhruma, Mohammed Omar J, Choudhury Ruhul, Dave Foram, Vaghela Poonam, Dubinina Elena, Parsons Tina, Durrant Lindy, Vankemmelbeke Mireille